Imedex E-learning (audio)

Novel Agents in Elderly CLL Patients: Should the Approach be Different? - Jennifer A Woyach, MD

Informações:

Sinopsis

Positioning PI3K Inhibitors in the CLL/SLL Treatment Paradigm: New Options for Relapsed/Refractory Disease